OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Switching Vedolizumab from IV to SC Injection in Inflammatory Bowel Disease Patients with Active Disease: Real-World Experience from a German IBD Cohort
Alica Kubesch, N. A. Kruse, Florian Jungheim, et al.
Journal of Clinical Medicine (2023) Vol. 12, Iss. 24, pp. 7657-7657
Open Access | Times Cited: 4
Alica Kubesch, N. A. Kruse, Florian Jungheim, et al.
Journal of Clinical Medicine (2023) Vol. 12, Iss. 24, pp. 7657-7657
Open Access | Times Cited: 4
Showing 4 citing articles:
An international multicentre study of SwiTching from Intravenous to subcutaneous inflixiMab and vEdolizumab in inflammatory bowel diseases: The TIME study
Ferdinando D’Amico, Luca Massimino, Giulia Palmieri, et al.
European Journal of Clinical Investigation (2024) Vol. 54, Iss. 11
Open Access | Times Cited: 1
Ferdinando D’Amico, Luca Massimino, Giulia Palmieri, et al.
European Journal of Clinical Investigation (2024) Vol. 54, Iss. 11
Open Access | Times Cited: 1
Take vedolizumab home: transition from intravenous to subcutaneous treatment
Kaituo Huang, Lingya Yao, Jing Liu, et al.
Therapeutic Advances in Chronic Disease (2024) Vol. 15
Open Access | Times Cited: 1
Kaituo Huang, Lingya Yao, Jing Liu, et al.
Therapeutic Advances in Chronic Disease (2024) Vol. 15
Open Access | Times Cited: 1
Systematic review with meta-analysis of the effectiveness of subcutaneous biologics versus intravenous biologics in inflammatory bowel diseases
Alexander T. Elford, Rishni Heldt, Shahed Kamal, et al.
European Journal of Gastroenterology & Hepatology (2024)
Closed Access
Alexander T. Elford, Rishni Heldt, Shahed Kamal, et al.
European Journal of Gastroenterology & Hepatology (2024)
Closed Access
Outcomes of treatment cessation after switching to subcutaneous vedolizumab treatment in inflammatory bowel diseases
Péter Bacsúr, Tamás Resál, Patrícia Sarlós, et al.
Therapeutic Advances in Gastroenterology (2024) Vol. 17
Open Access
Péter Bacsúr, Tamás Resál, Patrícia Sarlós, et al.
Therapeutic Advances in Gastroenterology (2024) Vol. 17
Open Access
